Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:42 PM
Ignite Modification Date:
2025-12-24 @ 12:42 PM
NCT ID:
NCT02749461
Eligibility Criteria:
Inclusion Criteria:
* Preterm infants born between 24 0/7 and 36 6/7 weeks of gestation will be included if they are expected to undergo 5 routine heel capillary blood samples during the first 14 days of life; if they are ventilated or not ventilated; and if their parents give informed consent.
* Term infants born between 37 0/7 and 42 0/7 weeks of gestation will be included if they are expected to have at least 2 routine heel capillary blood samples during the first days of life and if their parents give informed consent.
Exclusion Criteria:
* Grade III oder IV intraventricular haemorrhaging
* Severe life-threatening malformation or suffer from any condition involving partial or total loss of sensitivity
* pHa \< 7.15 (umbilical cord)
* Surgery for any reason
* Congenital malformation affecting brain circulation and cardiovascular system
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
24 Weeks
Maximum Age:
41 Weeks
Study:
NCT02749461
Study Brief:
Protocol Section:
NCT02749461